Showing results (1-10 of 546) with videos related to
Sort By:
Pageof 55
Hematological Oncology|June 15, 2025
Peripheral T-Cell Lymphoma: What's Next?Sang Eun Yoon, Won Seog KimThe Korean Journal of Internal Medicine|November 23, 2019
Asian variant of intravascular large B-cell lymphoma: a comparison of clinical features based on involvement of the central nervous systemSang Eun Yoon, Won Seog Kim, Seok Jin KimJournal of Hematology & Oncology|December 21, 2018
Treatment of localized extranodal NK/T cell lymphoma, nasal type: a systematic reviewSeok Jin Kim, Sang Eun Yoon, Won Seog KimAnnals of Laboratory Medicine|January 11, 2024
Current Challenges in Chimeric Antigen Receptor T-cell Therapy in Patients With B-cell Lymphoid MalignanciesSeok Jin Kim, Sang Eun Yoon, Won Seog KimJournal of Cancer|April 15, 2021
Impact of transformation on the survival of patients diagnosed with follicular lymphoma that progressed within 24 monthsSang Eun Yoon, Junhun Cho, Won Seog Kim, et al.Blood Research|June 30, 2020
Immune checkpoint inhibitors in patients with pretreated HodgkinÊs lymphoma: a Korean single-center, retrospective studyJoon Young Hur, Sang Eun Yoon, Seok Jin Kim, et al.Annals of Hematology|May 15, 2023
Retrospective analysis of diagnosis and therapeutic strategies for patients with hepatosplenic T cell lymphomaYoungkyung Jeon, Sang Eun Yoon, Junhun Cho, et al.Cancer Research and Treatment|March 14, 2023
Efficacy of Salvage Treatments in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Including Chimeric Antigen Receptor T-Cell Therapy: A Systematic Review and Meta-AnalysisJinchul Kim, Jinhyun Cho, Sang Eun Yoon, et al.Cancer|February 22, 2023
TET2 and LILRB1 mutations are frequent in Epstein-Barr virus-positive diffuse large B-cell lymphoma especially in elderly patientsJunhun Cho, Eojin Kim, Sang Eun Yoon, et al.Cancer Medicine|June 16, 2023
A unique expression pattern of LAG3 distinct from that of other immune checkpoints in diffuse large B-cell lymphomaHyunjee Lee, Sang Eun Yoon, Seok Jin Kim, et al.Pageof 55